United Guardian (UG) Free Cash Flow Growth (5y) (2015 - 2026)
Powered by 
Analysis
United Guardian (UG) Free Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.54 Bn | 626.78 Bn | 17.26 Bn |
| 2 | AbbVie | 441.45 Bn | 434.88 Bn | 12.70 Bn |
| 3 | Merck | 364.78 Bn | 357.64 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.01 Bn | 259.32 Bn | 11.24 Bn |
| 5 | Pfizer | 158.95 Bn | 147.25 Bn | 10.94 Bn |
| 6 | Sanofi | 52.54 Bn | 45.16 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - |
| 8 | Incyte | 25.36 Bn | 20.82 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.31 Bn | 18.65 Bn | 683.80 Mn |
| 10 | United Guardian | 32.95 Mn | 23.36 Mn | 1.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.47% |
| Mar 31, 2026 | -9.17% |
| Dec 31, 2025 | -14.00% |
| Sep 30, 2025 | 40.65% |
| Jun 30, 2025 | -31.50% |
| Mar 31, 2025 | -24.36% |
| Dec 31, 2024 | -15.49% |
| Sep 30, 2024 | 5.63% |
| Jun 30, 2024 | 2.87% |
| Mar 31, 2024 | -16.35% |
| Dec 31, 2023 | 0.01% |
| Sep 30, 2023 | -1.23% |
| Jun 30, 2023 | -15.93% |
| Mar 31, 2023 | -24.06% |
| Dec 31, 2022 | -4.31% |
| Sep 30, 2022 | -10.03% |
| Jun 30, 2022 | -0.42% |
| Mar 31, 2022 | -51.86% |
| Dec 31, 2021 | 22.91% |
| Sep 30, 2021 | -2.73% |